opioid crisis
Top Ten most popular articles on Pharmafile.com this week
September 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10
Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …
Surgeon General calls for cultural shift in approach to opioid crisis
September 21, 2018Medical Communications Trump, US, opioid crisis, opioid epidemic, surgeon general
The Surgeon General of the United States has called for a cultural shift in the way in which Americans talk …
FDA expand REMS education program in effort against opioid crisis
September 19, 2018Research and Development FDA, IR, opioid crisis, opioids, rems
The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training …
US Senate pass bipartisan bill to tackle opioid crisis
September 18, 2018Manufacturing and Production Senate, US, epidemic, opioid, opioid crisis, politics
The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis. The bill, which was passed with …
Purdue-owning Sackler family own second opioid drug maker, FT reveals
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler
The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …
Opioid prescriptions hit 15 year low, as FDA’s Gottlieb reaffirms commitment against crisis
August 30, 2018Medical Communications FDA, opioid crisis, prescriptions, scott gottleib
The amount of opioids prescribed to patients in the United States has fallen to a 15 year low according to …
Emergent snaps up Adapt and its opioid overdose therapy for $735m
August 29, 2018Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma
Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …
New York sues Purdue Pharma over opioid crisis
August 15, 2018Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state
New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …
Letters to doctors reduce opioid prescriptions, study shows
August 10, 2018Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study
A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …
FDA announces policy shift to encourage new opioid addiction treatments
August 7, 2018Manufacturing and Production FDA, deaths, opioid crisis, overdose, policy
The US Food and Drug Administration (FDA) have announced that it is altering the way it evaluates a drug’s ability …
Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller
August 7, 2018Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma
The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
Fentanyl-related deaths spike in England and Wales
August 7, 2018Manufacturing and Production fentanyl, heroin, ons, opioid crisis, opioids, statistics
Deaths linked to the powerful opioid fentanyl have increased by 30% in England and Wales. Figures from the Office for …
Allergan sues Pfizer over opioid crisis lawsuits
August 3, 2018Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids
Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …
FDA panels vote to reject Pain Therapeutics’ abuse-deterrent opioid drug
June 27, 2018Research and Development, Sales and Marketing Remoxy, opioid crisis, opioids, pain therapeutics, pharma
Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …
Purdue culls 350 positions, eradicates sales force
June 21, 2018Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma
Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …
Latest content
FibroFind appoints Lee Borthwick as CEO
